Corrigendum: Psymberin, a marine-derived natural product, induces cancer cell growth arrest and protein translation inhibition

Divya L Dayanidhi; Jason A Somarelli; John B Mantyh; Gabrielle Rupprecht; Roham Salman Roghani; Sophia Vincoff; Iljin Shin; Yiquan Zhao; So Young Kim; Shannon McCall; Jiyong Hong; David S Hsu

doi:10.3389/fmed.2023.1193745

Corrigendum: Psymberin, a marine-derived natural product, induces cancer cell growth arrest and protein translation inhibition

Front Med (Lausanne). 2023 May 31:10:1193745. doi: 10.3389/fmed.2023.1193745. eCollection 2023.

Authors

Divya L Dayanidhi^#^{1

2}, Jason A Somarelli^#¹, John B Mantyh^{1

2}, Gabrielle Rupprecht^{1

2}, Roham Salman Roghani^{1

2}, Sophia Vincoff¹, Iljin Shin³, Yiquan Zhao³, So Young Kim⁴, Shannon McCall⁵, Jiyong Hong^{3

6}, David S Hsu^{1

2}

Affiliations

¹ Division of Medical Oncology, Department of Medicine, Duke University Medical Center, Durham, NC, United States.
² Center for Genomics and Computational Biology, Duke University, Durham, NC, United States.
³ Department of Chemistry, Duke University, Durham, NC, United States.
⁴ Department of Molecular Genetics and Microbiology, Duke University, Durham, NC, United States.
⁵ Department of Pathology, Duke University, Durham, NC, United States.
⁶ Department of Pharmacology and Cancer Biology, Duke University School of Medicine, Durham, NC, United States.

^# Contributed equally.

Abstract

[This corrects the article DOI: 10.3389/fmed.2022.999004.].

Keywords: high-throughput screening; patient-derived models of cancer; patient-derived organoids; precision medicine; protein translation; psymberin.

Publication types

Published Erratum